Regulation and Function of RFRP-3 (GnIH) Neurons during Postnatal Development by Matthew C. Poling & Alexander S. Kauffman
MINI REVIEW







Centre National de la Recherche
Scientifique, France
T. John Wu,





Medicine, University of California,
San Diego, Leichtag Building,
Room 3A-15, 9500 Gilman Drive,
#0674, La Jolla, CA 92093, USA
akauffman@ucsd.edu
Specialty section:
This article was submitted to
Experimental Endocrinology,
a section of the journal
Frontiers in Endocrinology
Received: 16 July 2015
Accepted: 07 September 2015
Published: 24 September 2015
Citation:
Poling MC and Kauffman AS (2015)
Regulation and function of RFRP-3




Regulation and function of RFRP-3
(GnIH) neurons during postnatal
development
Matthew C. Poling and Alexander S. Kauffman*
Department of Reproductive Medicine, University of California, San Diego, La Jolla, CA, USA
RFamide-related peptide-3 (RFRP-3) [mammalian ortholog to gonadotropin-inhibiting
hormone (GnIH)] potently inhibits gonadotropin secretion in mammals. Studies of RFRP-3
immunoreactivity and Rfrp expression (the gene encoding RFRP-3) in mammalian brains
have uncovered several possible pathways regulating RFRP-3 neurons, shedding light
on their potential role in reproduction and other processes, and pharmacological studies
have probed the target sites of RFRP-3 action. Despite this, there is currently no
major consensus on RFRP-3’s specific endogenous role(s) in reproductive physiology.
Here, we discuss the latest evidence relating to RFRP-3 neuron regulation and function
during development and sexual maturation, focusing on rodents. We highlight significant
changes in RFRP-3 and Rfrp expression, as well as RFRP-3 neuronal activation, during
key stages of postnatal and pubertal development and also discuss recent evidence test-
ing the requisite role of RFRP-3 receptors for normal pubertal timing and developmental
LH secretion. Interestingly, some findings suggest that endogenous RFRP-3 signaling
may not be necessary for the puberty timing, at least in some species, forcing new
hypotheses to be generated regarding this peptide’s functional significance to sexual
maturation and development.
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Introduction
Since their identification 15 years ago, both gonadotropin-inhibiting hormone (GnIH) and its
mammalian ortholog, RFamide-related peptide (RFRP-3), have become important research focuses
of neuroendocrinologists and reproductive biologists. When given exogenously, both peptides
potently inhibit the hypothalamic–pituitary–gonadal axis, and numerous studies have studied the
in vivo and in vitro effects of GnIH and RFRP-3 on luteinizing hormone (LH) secretion (1–6).
In rodents, as with most mammals, the neurons that produce RFRP-3 are a scattered population
localized exclusively within and immediately adjacent to the hypothalamic dorsal-medial nucleus
(DMN). This was first characterized by in situ hybridization (ISH) forRfrpmRNA (7) and confirmed
by immunohistochemistry with RFRP-3 or GnIH antibodies (2, 8).
In rodents, the primary focus of this review, RFRP-3 is thought to regulate LH secretion through
inhibition of gonadotropin-releasing hormone (GnRH) neurons rather than by direct action on
the pituitary. This model is supported by data, collected primarily in adult animals, showing that
RFRP-3 neural fibers appose GnRH neurons (2, 9, 10), RFRP-3’s high affinity receptor, Gpr147,
is expressed in some GnRH neurons (11), GnRH neuron electrical firing changes when RFRP-3
is applied to hypothalamic explants (4, 5), and RFRP-3 treatment suppresses LH secretion in a
Frontiers in Endocrinology | www.frontiersin.org September 2015 | Volume 6 | Article 1501
Poling and Kauffman Regulation and development of RFRP-3 neurons
GnRH-dependent manner (10). RFRP-3 may also regulate LH
secretion through additional indirect circuits in the brain, as only
a subset of GnRH neurons in rodents actually express Gpr147
mRNA (11). For example, RFRP-3 signaling may modulate the
activity of arcuate kisspeptin neurons, which also express the
Gpr147 receptor (12), or other upstream neuronal populations.
Interestingly, there are two reports of RFRP-3 stimulating LH
secretion in hamster species (13, 14), suggesting that in seasonal
rodents, RFRP-3 may have stimulatory and inhibitory roles in
reproduction. Similar stimulatory effects of RFRP-3 have not been
reported in mice or rats in adulthood or development.
How do RFRP-3 Immunoreactivity and Rfrp
mRNA Levels Change in the Brain During
Development?
RFamide-related peptide immunoreactivity and Rfrp mRNA are
first detectable in the rat hypothalamus on embryonic day 16 (E16)
or E17 (15). Using BrdU labeling to mark neurogenesis, we know
that RFRP-3 immunoreactive neurons are born as early as E12,
with most RFRP-3 neurons born on E13-E14 (16), consistent with
the neurogenesis of theDMN region itself (17). There areminimal
detectable RFRP-3 projections during the embryonic stage, as
RFRP-3 fibers are nearly absent before or at birth (15). However,
by the second and third postnatal weeks, RFRP-3 immunoreactive
fibers are clearly visible in some proximal hypothalamic nuclei,
such as the arcuate, lateral hypothalamic area, and paraventricular
nuclei, as well as non-hypothalamic sites, such as the thalamus
and midbrain (15). RFRP-3 fibers do not reach some of their
more distal targets, such as the spinal cord, until after puberty is
complete (15).
The first two studies to examine postnatal developmental
changes in neural Rfrp mRNA in rodents used qPCR on either
hypothalamic dissections or micropunches. Substantial increases
in Rfrp mRNA between neonatal/juvenile and peripubertal rats
were observed in both sexes (18, 19). However, Iwasa’s study
showed a significant decrease in Rfrp expression after puberty
in male, but not female, rats, whereas Quennell and colleagues
reported no significant decrease for either sex between peripuber-
tal ages and adults.
Our lab also examined Rfrp expression over development by
measuring Rfrp levels in newborn and adult mice by ISH. We
found that not only did Rfrp cell number change markedly over
postnatal development, but the levels of Rfrp mRNA in each
cell was dramatically different between the two ages. At birth,
there were numerous Rfrp neurons detected, but in adulthood,
the number of detectable neurons expressing Rfrp was notably
less (Figure 1). However, the relative amount of Rfrp mRNA per
neuron, indicated by the number of silver grains per individual
FIGURE 1 | Changes in neural Rfrp expression during postnatal development in mice. (A) Between the day of birth and adulthood, there are significant
changes in the expression of certain subtypes of Rfrp neurons (categorized based on their Rfrp expression levels). Low-expressing (LE) Rfrp cells (yellow arrowheads)
are the predominate subtype at birth whereas high-expressing (HE) Rfrp cells (red arrows) are first detectable during the 2nd week of postnatal life and remain
present through adulthood. (B) Three graphic representations of Rfrp cell number, total Rfrp expression levels in the brain, and Rfrp neuronal activation (measured by
c-Fos co-expression) during rodent postnatal development. P=postnatal day. The purple shading represents the approximate ages when puberty occurs.
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cell cluster, was higher in adults. This dramatic change in Rfrp
mRNA levels per cell demonstrated that while Rfrp cell number
is decreasing during postnatal development, each Rfrp cell is a
producing, on average,more RfrpmRNA as the animal ages.
To further investigate this intriguing developmental change,
ISH was performed for Rfrp mRNA at multiple postnatal ages
in mice, and each individual Rfrp cell was categorized as either
low expressing (LE) or high expressing (HE) based on the level
of mRNA being expressed by that cell (11, 20). We found that
the total number of detectable Rfrp cells was highest at birth and
significantly dropped through all postnatal ages, with the fewest
Rfrp neurons present in adulthood. This developmental pattern
of Rfrp neurons was the same for both sexes (20). Interestingly,
the total amount of Rfrp mRNA present in the DMN increased
around PND 6 and peaked at PND 12 before dropping again at
subsequent older ages. This robust juvenile increase in total Rfrp
mRNA reflects a large developmental increase in the number of
identifiable HE Rfrp cells, which substantially increase in preva-
lence and peak around PND 12 before dropping significantly in
number at older pubertal and adult ages (20). Conversely, the
number of LE Rfrp cells decreases slowly and steadily from birth
to adulthood, being lowest in adulthood (20). Currently, the phe-
notypic and functional difference between HE and LE Rfrp cells
is unknown. However, the HE cell population appears to be the
more responsive of the two subtypes to physiological challenges,
such as sex steroid treatments and leptin deficiency, as HE cells
change more severely than the LE subpopulation (11, 20).
We also examined later postnatal ages in female mice around
puberty, using a detailed day-to-day time course. The total num-
ber of Rfrp cells was found to decrease around PND20-21, around
weaning and ~1week before the onset of female puberty (21).
However, this outcome differs from the previously published qRT-
PCR rat experiments (18, 19), as neither of those studies showed
a consistent decrease in Rfrp expression between prepubertal and
adult animals. Additionally, the observed juvenile increase in total
Rfrp expression in mice appears to occur later in development
in rats, even when accounting for different developmental time-
lines between rats and mice. In mice, using ISH, Rfrp expression
peaks in the second week of life and drops to adult-like levels
by the end of third week of postnatal life, about a week before
externalmarkers of puberty are noticeable. In rats,Rfrp expression
increases steadily during postnatal and pubertal development, and
only drops to adult-like levels at ages after puberty is completed
[note: a significant post-pubertal decrease was only observed in
male rats (19)]. However, a newer experiment using qRT-PCR
to measure Rfrp expression in brains of female mice produced a
similar pattern as in our findings: total Rfrp expression increases
in prepubertal mice then drops at the time of vaginal opening
(22). We note that all values in that study were normalized to Rfrp
expression on PND 24, which is after the age when most Rfrp
gene expression changes are typically observed in mice in our ISH
experiments. Furthermore, those data are from animals that were
pooled based on the day they completed vaginal opening, rather
than a specific postnatal day. While the implications of the dis-
crepancies in these developmental profiles are currently unclear,
the consistent finding is that there is a marked upregulation of
RFRP-3 between birth and puberty in rodents. This conclusion is
supported by both mRNA and protein data in several species, but
the functional significance of this developmental change remains
to be determined.
What Regulates Developmental Changes in
Neural Rfrp Expression?
Few studies have moved beyond routine descriptive characteriza-
tion of changes in RFRP-3 orRfrp expression during postnatal life.
One study questioned whether the majority of changes observed
in Rfrp expression and cell number during postnatal development
reflected neuronal apoptosis as a possible underlying mechanism
(11). Using knockoutmice deficient in BCL2-associated X protein
(BAX, a major factor causing neuronal apoptosis), we found, in
adult male mice, a small but significant increase in the total num-
ber of Rfrp cells present in the brain compared to WT mice. This
higher number of overall Rfrp cells was primarily due to increased
numbers of detectable LE Rfrp cells. However, while the adult
BAX KO mice had more total Rfrp cells than WTs, the observed
difference in cell number was not nearly as great as the difference
seen between the day of birth and adulthood in normal WTmice.
Thus, because adult BAX KO males did not have a newborn-like
number of Rfrp neurons, it appears that BAX-mediated apoptosis
is not solely responsible for the large overall decrease in cell
number seen during development. Therefore, in addition to a
minor effect of apoptosis via BAX, other regulatory factors or
developmental processes must also be involved in modifying the
temporal expression of Rfrp neurons throughout development.
Since neuronal apoptosis (via BAX) cannot completely explain
the decrease in Rfrp neuron number during postnatal develop-
ment, these neurons are likely undergoing regulatory changes
in Rfrp expression that (1) decrease the Rfrp mRNA expression
in some cells to a degree that makes them undetectable by ISH
while (2) simultaneously increasing Rfrp expression in a subset of
neurons, thereby generating the HE Rfrp cell population that is
virtually absent at birth but which emerges in juvenile life. The
mechanisms causing this maturation of the Rfrp system may be
intrinsic to this neuropeptide cell population, but more likely, an
extrinsic factor is acting on the Rfrp neuron population to dictate
specific changes in gene expression in the various subtypes of Rfrp
neurons.
A factor that was hypothesized to regulate this developmen-
tal change was the adipocyte hormone, leptin. Leptin is well
known for its regulation of body weight by regulating feeding
behavior and energy expenditure. Additionally, there are demon-
strated developmental effects of leptin on hypothalamic neurite
outgrowth during postnatal juvenile life. In rodents, during the
second week of postnatal life, serum leptin levels transiently
increase several fold for several days and then return to normal
low levels by postnatal day 16 (23). This juvenile “leptin surge” has
functional significance in the hypothalamus, regulating neurite
outgrowth and projections from the arcuate nucleus to the DMN,
where RFRP-3 neurons reside (24, 25). In regards to RFRP-3,
we found that a small subset of Rfrp neurons express the long
form leptin receptor mRNA, suggesting that leptin could poten-
tially act directly in those neurons. Supporting this possibility, we
detected impaired Rfrp expression in adult Obese (Ob) mice (20),
which produce a non-functional leptin peptide, rendering them
morbidly obese in adulthood and reproductively incompetent
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(26, 27). Because there was a significant alteration of RfrpmRNA
expression in adult Ob mice, we tested whether Rfrp neuron
maturation during juvenile life was dependent on proper leptin
actions via the leptin surge. First, we measured serum leptin dur-
ing postnatal development in normal female mice to determine if
changes in leptin levels correlate with changes in Rfrp expression.
We found that both leptin and Rfrp expression are similarly low
at birth and the late neonatal period, and that both measures then
start to rise in juvenile life. Serum leptin levels were highest just
before and during the peak of Rfrp expression observed around
postnatal day 12 (20), showing nice symmetry in the timing of
developmental changes in these two measures. This experiment
was followed up with an examination of Rfrp expression in post-
natal Ob mice and their WT littermates. We hypothesized that
leptin signaling is required, directly or indirectly, for the nor-
mal pattern of Rfrp neuron development in juveniles. However,
despite the strong correlation between developmental Rfrp and
leptin changes observed in normal mice, we found no differences
between Ob and WT mice in any measure of Rfrp expression
during postnatal development (20). Since leptin is not required
for the developmental changes inRfrp expression, othermetabolic
hormones, such as ghrelin or insulin (28–30), or reproductive
hormones from maturing gonads (31–34), may be involved in
driving the Rfrp developmental pattern during these postnatal
ages.
What Role Does RFRP-3 Have in
Peripubertal Life?
Given the dramatic developmental changes inRfrp expression and
neuronal activation during prepubertal and peripubertal life, it
is possible that RFRP-3 regulates pubertal timing. Several inves-
tigators have used different methods to block RFRP-3’s produc-
tion or action to test this hypothesis. First, a small interfering
RNA was designed to knockdown RFRP-3 in prepubertal male
rats (35). After 2weeks of treatment, the knockdown success-
fully decreased RFRP-3 immunoreactivity and increased serum
LH. However, this treatment was surprisingly unable to alter
the timing of pubertal development (35). Second, a Gpr147 KO
mouse line was developed in order to test the necessity of RFRP-3
signaling for mouse reproductive function (36). Gpr147 is the
primaryG-protein coupled receptor for RFRP-3, as determined by
receptor–ligand binding and functional assays (7, 37). Gpr147 KO
mice were confirmed to be unresponsive to exogenous RFRP-3,
showing no decrease in LH after central RFRP-3 injections. Yet,
surprisingly, Gpr174 KO females had no significant advancement
or delay in pubertal timing, as measured by vaginal opening. Col-
lectively, these two independent findings suggest that endogenous
RFRP-3, acting on Gpr147, does not have a major role in timing
puberty onset, at least in rodents. However, estrous cyclicity was
slightly impaired in adult Gpr147 KO mice, which had a small
but significant decrease in the time spent in diestrous, suggest-
ing RFRP-3 may still have meaningful roles in reproduction in
adulthood.
Despite the findings above, it remains possible that RFRP-3
may still have a developmental role in controlling LH secretion
in juvenile or prepubertal mice, but not robustly altering puberty
timing. Indeed, the same study that demonstrated normal puberty
in Gpr147 KOs reported that prepubertal Gpr147 KO males have
higher LH levels than their WT counterparts, suggesting that
endogenous RFRP-3 is important in modulating prepubertal LH
secretion. Interestingly, this genotype difference was normalized
after puberty, with both KOs and WTs having similar adult LH
levels (36). Therefore, RFRP-3 may not have a critical role in
the timing of puberty onset or duration, but may still act to
suppress LH secretion prior to the pubertal period, which would
match the developmental stage when neural Rfrp levels are high-
est. Most recently, our lab examined the neuronal activation of
multiple reproductive neuropeptides during the prepubertal and
peripebuteral periods in C57BL6 female mice (21). Of the three
reproductive neuropeptide systems examined, kisspeptin, neu-
rokinin B and RFRP-3, Rfrp neurons were the only population to
demonstrate a significant change in neuronal activation during
the peripubertal period. More specifically, c-Fos co-expression,
which marks recently activated neurons, was significantly higher
in Rfrp neurons on PND 15 than on PND 21, reflecting lower
neuronal activation at the latter age. Afterward, throughout sub-
sequent pubertal ages (~PND 22-30), c-Fos induction in Rfrp
neurons remained consistent around 40% versus the higher lev-
els of neuronal activation ~60% at the earlier prepubertal age
(PND 15). From these data, we infer that RFRP-3 secretion and
actions on the reproductive axis are decreased at PND 21 and
FIGURE 2 | Schematic depicting how Rfrp neurons may fit into mouse
neuroanatomy and physiology. Sex steroids are known to inhibit Rfrp
expression, primarily through estrogen pathways, while leptin appears to have
no major direct effect on Rfrp neurons, at least in development. There appear
to be other developmental factors that regulate the development of Rfrp
expression which are both stimulatory and inhibitory that remain to be
determined. RFRP-3 neurons have efferents that may regulate LH secretion
by acting directly on GnRH neurons, or indirectly on GnRH neurons through
arcuate kisspeptin neurons or other yet-to-be identified neuronal populations.
Other RFRP-3 neuronal target areas include the paraventricular nucleus (PVN)
and the spinal cord, and RFRP-3 has unknown effects on these
non-reproductive regions.
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throughout puberty relative to a stronger inhibitory tone that
potentially exists on PND 15. Additionally, we speculate that at
some point between PND15 and PND21, there are either changes
in the upstream stimulatory input onto RFRP-3 neurons or that
the RFRP-3 neurons are intrinsically changing their activity and
secretion by an undetermined mechanism.
Collectively, the above experiments suggest that RFRP-3 is
unlikely to be a major player in substantially impacting the tim-
ing of pubertal onset or progression because (1) knocking down
RFRP-3 production during puberty has no effect on pubertal
time, (2) Gpr147 KO mice have normal timing of vaginal open-
ing, and (3) any notable decrease in Rfrp gene expression or
neuronal activation occurs multiple days, if not longer, before
external markers of puberty are evidenced. Nonetheless, RFRP-3
may still prove to have role in restraining the reproductive axis
before puberty can start or proceed. A recently published report
demonstrated that RFRP-3 is able to suppress LH secretion in
prepubertal female mice, but only in the presence of estradiol
(22). It currently remains unclear why RFRP-3 had no stimulatory
effect in the absence of estrogen. Regardless, this is the first report
to examine the effect of RFRP-3 on LH secretion in prepuber-
tal mice, and confirms the assumption that RFRP-3 can have
bioactivity at these younger non-adult ages. Within the context of
dramatic developmental changes in Rfrp expression and RFRP-3
neuronal firing discussed above, these new data suggest that
RFRP-3 may have a role in maintaining the reproductive axis in a
prepubertal quiescent state until other pubertal regulators initiate
puberty.
Conclusion
RFamide-related peptide-3 suppresses LH secretion when given
exogenously. However, additional exploration into RFRP-3’s func-
tional position in the mammalian reproductive axis has been
limited. RFRP-3 neurons have distinct and quantifiable changes
throughout development, hinting at a role in regulating puberty,
but this was not corroborated by knockout and knockdown stud-
ies. Thus, RFRP-3’s developmental function is not immediately
clear (Figure 2). Knockoutmouse studies have shown that RFRP-3
neuron development is not strongly regulated by BAX-mediated
apoptosis or by leptin, opening the possibility of other novelmech-
anisms that may influence the maturation of RFRP-3 neurons
(Figure 2). Thus, RFRP-3’s specific developmental role is still
being elucidated, leaving multiple avenues to explore. How does
RFRP-3 regulate LH secretion in prepubertal animals, and why is
it influenced by estrogen? Why does RFRP-3 neuron activation
decrease after weaning? Why do some Rfrp neurons express high
levels of Rfrp mRNA while others do not? Is there a functional
significance to the robust Rfrp changes between birth and juvenile
life and then again before adulthood? Answering these questions
will further identify the role of RFRP-3 in development and
reproduction in general.
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